“…Extensive investigations have documented the existence of high-affinity DHP binding sites in cardiac membranes (Bellemann et al, 1981;Holck et al, 1982; Triggle & Janis, 1984a). However, when comparing results of pharmacological and electrophysiological studies (Lee & Tsien, 1983; Janis & Triggle, 1984) with those from binding studies (Holck et al, 1982;1984), a large discrepancy (> 10 fold) is encountered in the concentrations of DHPs required to suppress myocardial ICa and to inhibit [3H1-nitrendipine binding. Recent investigations suggest that the Ca2" channel blocking potencies of DHPs such as nitrendipine (Bean, 1984;Reuter et al, 1985) or 'Author for correspondence. nisoldipine (Sanguinetti & Kass, 1984) Hof, 1985).…”